SC5D
protein-codingsterol-C5-desaturase, the group of Fatty acid hydroxylase domain containing
Gene summary
This gene encodes an enzyme of cholesterol biosynthesis. The encoded protein catalyzes the conversion of lathosterol into 7-dehydrocholesterol. Mutations in this gene have been associated with lathosterolosis. Alternatively spliced transcript variants encoding the same protein have been described. [provided by RefSeq, Jul 2008]
- SC5DL
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~20.7 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0011816
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0011816
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0011816
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0011816
Submitter: G2P
Clinical Genomic Database (CGD)
Manifestation: Biochemical; Craniofacial; Gastrointestinal; Musculoskeletal; Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
Comments: Lipid storage has been reported as being aggravated by supplemental cholesterol
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to SC5D variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_006918.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 24 | 26 | |||
| missense | 3 | 2 | 51 | 8 | 1 | 65 |
| nonsense | 1 | 4 | 5 | |||
| start loss | 0 | |||||
| frameshift | 1 | 4 | 5 | |||
| splice donor/acceptor (+/-2bp) | 3 | 3 | ||||
| Total | 3 | 4 | 64 | 32 | 1 | 104 |
Highest pathogenic variant AF is 0.00010295493
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_008849.2 | 4 | MANE Select | |
| Ensembl | ENSP00000264027.4 | 4 | MANE Select | |
| RefSeq | NP_001020127.1 | 4 | Standard | |
| Ensembl | ENSP00000376539.2 | 4 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Steroid biosynthesis - Homo sapiens (human)
- Simvastatin Action Pathway
- Pravastatin Action Pathway
- Atorvastatin Action Pathway
- Hyper-IgD syndrome
Biological Process
- lipid metabolic process
- sterol biosynthetic process
- cholesterol biosynthetic process via desmosterol
- cholesterol biosynthetic process via lathosterol
- regulation of cholesterol biosynthetic process
Molecular Function
- C-5 sterol desaturase activity
- iron ion binding
Cellular Component
- endoplasmic reticulum membrane
- integral component of membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000264027
- Coding exons
- 4
- Length
- 16242
- Individuals with no LoFs
- 125708
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 37
- Defined
- 125745
- p
- 0.000147
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.721 | 139 | 165 | 0.842 | 0.00000861 | 1994 |
| Missense (PolyPhen) | 47 | 61.176 | 0.76827 | 787 | ||
| Synonymous | 0.749 | 51 | 58.3 | 0.875 | 0.00000303 | 543 |
| Loss of Function | 1.66 | 6 | 12.3 | 0.490 | 6.73e-7 | 140 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0.00017 | 0.00017 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00016 | 0.00016 | rare |
| Finnish | 0.000092 | 0.000092 | rare |
| European (Non-Finnish) | 0.00021 | 0.00021 | rare |
| South Asian | 0.000065 | 0.000065 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Catalyzes a dehydrogenation to introduce C5-6 double bond into lathosterol.;
- Disease
- DISEASE: Lathosterolosis (LATHST) [MIM:607330]: Autosomal recessive disorder characterized by a complex phenotype, including multiple congenital anomalies, mental retardation, and liver disease. {ECO:0000269|PubMed:12189593, ECO:0000269|PubMed:12812989}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.151
Intolerance Scores
- RVIS EVS
- -0.25
- RVIS percentile EVS
- 35.75
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |